Literature DB >> 30565031

Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools.

Sebastiaan C Goulooze1, Elke H J Krekels1, Thomas Hankemeier1, Catherijne A J Knibbe2,3.   

Abstract

During covariate modeling in pharmacometrics, computational time can be reduced by using a fast preselection tool to identify a subset of promising covariates that are to be tested with the more computationally demanding likelihood ratio test (LRT), which is considered to be the standard for covariate selection. There is however a lack of knowledge on best practices for covariate (pre)selection in pharmacometric repeated time-to-event (RTTE) models. Therefore, we aimed to systematically evaluate the performance of three covariate (pre)selection tools for RTTE models: the likelihood ratio test (LRT), the empirical Bayes estimates (EBE) test, and a novel Schoenfeld-like residual test. This was done in simulated datasets with and without a "true" time-constant covariate, and both in the presence and absence of high EBE shrinkage. In scenarios with a "true" covariate effect, all tools had comparable power to detect this effect. In scenarios without a "true" covariate effect, the false positive rates of the LRT and the Schoenfeld-like residual test were slightly inflated to 5.7% and 7.2% respectively, while the EBE test had no inflated false positive rate. The presence of high EBE shrinkage (> 40%) did not affect the performance of any of the covariate (pre)selection tools. We found the EBE test to be a fast and accurate tool for covariate preselection in RTTE models. The novel Schoenfeld-like residual test proposed here had a similar performance in the tested scenarios and might be applied more readily to time-varying covariates, such as drug concentration and dynamic biomarkers.

Keywords:  covariate model building; empirical Bayes estimate; non-linear mixed effects modeling; repeated time-to-event

Mesh:

Substances:

Year:  2018        PMID: 30565031     DOI: 10.1208/s12248-018-0278-6

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  15 in total

1.  A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic effect of ondansetron.

Authors:  E H Cox; C Veyrat-Follet; S L Beal; E Fuseau; S Kenkare; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

2.  Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.

Authors:  Radojka M Savic; Mats O Karlsson
Journal:  AAPS J       Date:  2009-08-01       Impact factor: 4.009

3.  Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics: the Perception of Shrinkage and Likelihood Ratio Test.

Authors:  Xu Steven Xu; Min Yuan; Haitao Yang; Yan Feng; Jinfeng Xu; Jose Pinheiro
Journal:  AAPS J       Date:  2016-10-19       Impact factor: 4.009

4.  Assessing the fit of parametric cure models.

Authors:  E Paul Wileyto; Yimei Li; Jinbo Chen; Daniel F Heitjan
Journal:  Biostatistics       Date:  2012-11-28       Impact factor: 5.899

Review 5.  Covariate selection in pharmacometric analyses: a review of methods.

Authors:  Matthew M Hutmacher; Kenneth G Kowalski
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

6.  Kernel-Based Visual Hazard Comparison (kbVHC): a Simulation-Free Diagnostic for Parametric Repeated Time-to-Event Models.

Authors:  Sebastiaan C Goulooze; Pyry A J Välitalo; Catherijne A J Knibbe; Elke H J Krekels
Journal:  AAPS J       Date:  2017-11-27       Impact factor: 4.009

7.  Repeated Time-to-event Analysis of Consecutive Analgesic Events in Postoperative Pain.

Authors:  Rasmus Vestergaard Juul; Sten Rasmussen; Mads Kreilgaard; Lona Louring Christrup; Ulrika S H Simonsson; Trine Meldgaard Lund
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

8.  Evaluation of estimation methods and power of tests of discrete covariates in repeated time-to-event parametric models: application to Gaucher patients treated by imiglucerase.

Authors:  Marie Vigan; Jérôme Stirnemann; France Mentré
Journal:  AAPS J       Date:  2014-02-26       Impact factor: 4.009

9.  Basic concepts in population modeling, simulation, and model-based drug development.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-09-26

10.  Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-04-17
View more
  1 in total

1.  Machine learning-guided covariate selection for time-to-event models developed from a small sample of real-world patients receiving bevacizumab treatment.

Authors:  Eleni Karatza; Apostolos Papachristos; Gregory B Sivolapenko; Daniel Gonzalez
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-08-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.